Interview mit: Alexander Rosenkranz, Florian Thalhammer; Kommentar von: Herbert Watzke • Aktuell • UIM 08|2016
•
14.11.2016
Melden Sie sich bitte hier kostenlos und unverbindlich an, um den Inhalt vollständig einzusehen und weitere Services von www.medmedia.at zu nutzen.
Array
(
[0] => post
[1] => custom_css
[2] => customize_changeset
[3] => oembed_cache
[4] => ap-punkte
[5] => apotheker-krone
[6] => apokolleg
[7] => apo-raetsel
[8] => aerzte-krone
[9] => diabetes-forum
[10] => faktenrheumatologie
[11] => fokus
[12] => gyn-aktiv
[13] => klinik-ausgaben
[14] => das-medizinprodukt
[15] => nephro-script
[16] => neue-horizonte
[17] => neurologisch-ausg
[18] => pn
[19] => medizin-verstehen
[20] => pharm-austria
[21] => die-punkte
[22] => spectrumdermatologie
[23] => spectrum-onkologie
[24] => spectrum-osteoporose
[25] => spectrum-psychiatrie
[26] => spectrum-urologie
[28] => zahn-krone
[29] => zahn-punkte
[30] => arzt-und-praxis
[31] => apoteam
[32] => nl-banner
[33] => spectrum-pathologie
[34] => diepunkteon
[35] => diepunkteon-aktuell
[36] => diepunkteonpages
[37] => spio
[38] => spio-tumor
[39] => spio-substanz
[40] => molonko-target
[41] => molonko-indication
[42] => molonko-substance
[43] => molonko-product
[44] => personen
[45] => nextdoc
[46] => nextdoc_job
[47] => nextdoc_employer
[48] => relatus-med
[49] => relatus-pharm
[50] => congress-x-press
[51] => cxp-article
[52] => acf-field-group
[53] => acf-field
[54] => bp-email
[55] => experts
)
2575univ-innere-medizin
